Clinical Trials in Oncology & Hemato-Oncology
Illingworth is set to attend The 2nd International Congress on Clinical Trials in Oncology and Hemato-Oncology (ICTO2018) scheduled to take place in Berlin, Germany from 19-20 February 2018.
The congress will again bring together world renowned speakers in the field of Clinical Trials in Oncology and Hemato-Oncology. The event welcomes oncology professionals, treatment experts, CRO’s, industry leaders and other experts to the majestic city of Berlin. Illingworth are hopeful ICTO2018 will provide an outstanding scientific, educational and networking experience.
The congress will focus on areas including:
- Design of clinical trials in the new era Personalized cancer medicine
- Monitoring of Trials and Statistics
- Regulations – Survival based Medicine
- Phase 4 Trials
- Expanded access trials
- Ethics and Patients’ Rights
- Healthcare economy